Intelligent Cold Therapy-Compression Therapy System for Personalized Treatment

Publication ID: 24-11857491_0005_PTD

Published: October 28, 2025

Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Intelligent Cold Therapy-Compression Therapy System for Personalized Treatment,” Published Technical Disclosure No. 24-11857491_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857491_0005_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,491.

Summary of the Inventive Concept

An AI-powered, wearable cold therapy-compression therapy system integrating real-time patient monitoring, automated temperature control, and advanced nanomaterials for enhanced performance, enabling personalized treatment and remote healthcare guidance.

Background and Problem Solved

The original patent's integrated cold therapy-compression therapy assembly has limitations in terms of patient monitoring, treatment customization, and device maintenance. The new inventive concept addresses these limitations by incorporating AI, advanced materials, and telemedicine capabilities to provide more effective and personalized treatment.

Detailed Description of the Inventive Concept

The new inventive concept consists of a wearable, modular treatment pad with integrated sensors for real-time patient monitoring, a portable, rechargeable coolant reservoir with automated temperature control, and an AI algorithm for optimizing treatment parameters. The system incorporates advanced nanomaterials for enhanced heat transfer and compression performance. The telemedicine platform enables remote patient monitoring and treatment guidance by healthcare professionals. The modular, 3D-printed device design allows for interchangeable treatment modules and machine learning-based predictive maintenance.

Novelty and Inventive Step

The new claims introduce AI-powered patient monitoring, automated temperature control, and advanced nanomaterials, which are not present in the original patent. The integration of these features enables personalized treatment and remote healthcare guidance, making the new inventive concept novel and non-obvious compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments could include integrating the AI algorithm with electronic health records, incorporating additional sensors for monitoring patient vital signs, or using alternative materials for the treatment pad and coolant reservoir. Variations could include designing the system for specific medical conditions or developing a miniature version for portable use.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in the healthcare industry, particularly in the fields of sports medicine, physical therapy, and pain management. The system's ability to provide personalized treatment and remote healthcare guidance could lead to improved patient outcomes and reduced healthcare costs.

CPC Classifications

Section	Class	Group
A	A61	A61H9/0092
A	A61	A61F7/0085
A	A61	A61F2007/0042
A	A61	A61F2007/0056
A	A61	A61H2201/0207
A	A61	A61H2201/0214
A	A61	A61H2201/0242
A	A61	A61H2201/5023
A	A61	A61H2201/5071
A	A61	A61H2205/102

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device technology focusing on therapeutic systems for cold and compression therapy, specifically wearable medical treatment devices with sensor integration and temperature control mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in thermal management, sensor technologies, microprocessor control systems, and therapeutic device design, typically holding a masters or PhD with 3-5 years of industry experience

Obviousness Rationale

A PHOSITA would recognize that integrating AI-powered monitoring and automated temperature control into an existing cold therapy-compression device represents a predictable technological evolution. The source patent's microprocessor-controlled coolant system provides a clear technological foundation for more advanced sensor and algorithmic interventions. The proposed variations represent incremental improvements using known techniques in medical device design and machine learning technologies.

Obvious Combinations & Variations

Source Patent Element

Microprocessor controlling operation of coolant pump

PTD Variation

AI algorithm for optimizing treatment parameters and temperature control

Obviousness Reasoning

Extending microprocessor control to include machine learning represents a predictable technological progression using known algorithmic techniques

Source Patent Element

Reservoir container with coolant mixing chamber

PTD Variation

Portable rechargeable coolant reservoir with integrated nanomaterials for enhanced heat transfer

Obviousness Reasoning

Material science improvements to existing thermal management systems constitute a standard design optimization approach in medical device engineering

Source Patent Element

Cold therapy device with potential for external monitoring

PTD Variation

Telemedicine platform enabling remote patient monitoring and treatment guidance

Obviousness Reasoning

Integrating digital communication technologies with medical devices is a known trend in healthcare technology development

Source Patent Element

Modular device design with potential for configuration

PTD Variation

3D-printed modular device with interchangeable treatment modules

Obviousness Reasoning

Applying additive manufacturing techniques to medical device design represents a standard approach to increasing device flexibility and customization

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857491 and the technological context of cold therapy-compression devices, the variations disclosed herein would be considered obvious to a person having ordinary skill in the art. The incremental technological advancements represent predictable combinations of known techniques in medical device design, sensor integration, and algorithmic control systems, thereby rendering potential patent claims obvious and anticipatable as prior art.

Original Patent Information

Patent Number	US 11,857,491
Title	Integrated cold therapy-compression therapy assembly and associated treatment protocols
Assignee(s)	Breg, Inc.